Plausible role of INPP4A dysregulation in idiopathic pulmonary fibrosis

Meghana Arvind1,2, Bijay Pattnaik1,3, Atish Gheware1,2,4

  • 1Centre of Excellence for Translational Research In Asthma and Lung diseases (TRIAL), CSIR-Institute of Genomics and Integrative Biology, New Delhi, India.

PubMed

Insights

Inositol polyphosphate 4-phosphatase Type I A (INPP4A) shows altered expression in idiopathic pulmonary fibrosis (IPF). Its role in IPF is complex, varying with disease stage and lung region, impacting lung function.

Area of Science:

  • Cell Biology
  • Pulmonary Medicine
  • Biochemistry

Background:

  • Inositol polyphosphate 4-phosphatase Type I A (INPP4A) regulates cell proliferation and apoptosis.
  • INPP4A is crucial for lung homeostasis, but its role in chronic lung diseases is understudied.
  • Previous research from our group established INPP4A's function in these cellular processes.

Purpose of the Study:

  • To investigate the regulation of INPP4A in idiopathic pulmonary fibrosis (IPF).
  • To understand how INPP4A expression changes in different stages and regions of IPF lungs.

Main Methods:

  • Integration of public INPP4A gene expression data.
  • In vitro experiments.
  • Analysis of mouse models of pulmonary fibrosis.
  • Correlation with physiological lung function indices (FVC, DLCO).

Main Results:

  • INPP4A expression is altered in IPF, with changes dependent on disease stage and lung region.
  • INPP4A is upregulated in whole lung samples but downregulated in fibrotic regions.
  • INPP4A levels are elevated in early-stage IPF and negatively correlate with lung function.
  • Anti-INPP4A antibody treatment exacerbated bleomycin-induced lung injury in mice.

Conclusions:

  • INPP4A exhibits nuanced regulation in IPF, influenced by disease stage, cellular state, and fibrosis extent.
  • The findings suggest a complex role for INPP4A in IPF pathogenesis.
  • Targeting INPP4A may have differential effects depending on the specific disease context.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K